DaVita HealthCare Partners Inc. 4th Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Piper Jaffray Reiterates Overweight on DaVita (DVA) Following Strong 4Q
February 12, 2016 8:21 AM ESTPiper Jaffray maintained an Overweight rating on DaVita (NYSE: DVA), and cut the price target to $85.00 (from $90.00), following the company's 4Q earnings report. Adjusted EPS of $1.01 was $0.05 higher than consensus estimate of $0.96. Revenue increased 6.2% y/y to $3,534M, which was $36M higher than consensus of... More
DaVita (DVA) Tops Q4 EPS by 4c
February 11, 2016 4:51 PM ESTDaVita (NYSE: DVA) reported Q4 EPS of $1.01, $0.04 better than the analyst estimate of $0.97. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.5 billion.
For earnings history and earnings-related data on DaVita (DVA) click here.
... MoreDaVita (DVA) Tops Q4 EPS by 4c
February 11, 2016 4:16 PM ESTDaVita (NYSE: DVA) reported Q4 EPS of $1.01, $0.04 better than the analyst estimate of $0.97. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.5 billion.
For earnings history and earnings-related data on DaVita (DVA) click here.
... More